Articoli correlati a Adenosine, Cardioprotection, and Its Clinical Application:...

Adenosine, Cardioprotection, and Its Clinical Application: 194 - Rilegato

 
9780792399544: Adenosine, Cardioprotection, and Its Clinical Application: 194

Sinossi

It has been almost 15 years since the fIrst reports appeared indicating that adenosine exerted a .protective effect in ischemic and reperfused myocardium. Numerous experimental studies have shown that adenosine (both exogenous and endogenous adenosine) delays the onset of ischemic contracture, modulates myocardial metabolism during ischemia, attenuates reversible postischemic ventricular dysfunction (myocardial stunning), and reduces myocardial infarct size. Initial studies on adenosine's cardioprotective effect were based on its ability to stimulate postischemic ATP resynthesis, increase coronary blood flow, and reduce heart rate. Although these actions of adenosine are undoubtedly benefIcial to the ischemic/reperfused heart, it now appears that adenosine's cardioprotective effect may be exclusive of these properties. The immense growth in the number of articles on adenosine cardioprotection in the last several years has been related in large part to the hypothesis that adenosine plays a role in ischemic preconditioning. Ischemic preconditioning is the phenomenon in which a brief period of ischemia (and reperfusion) prior to a more prolonged occlusion reduces myocardial infarct size. This form of myocardial protection has received much interest because ischemic preconditioning has been shown to be the most potent means of reducing infarct size in all animal models thus far tested. In fact prior to studies implicating adenosine's role in ischemic preconditioning, adenosine's infarct reducing effect was not well recognized.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

Contenuti

I: Adenosine and Cardioprotection. 1. Adenosine and Cardioprotection; R.M. Mentzer, Jr., R. Lasley. II: Cardioprotection and Mechanisms of Ischemic And Reperfusion Injury. 2. Concept of Cardioprotection Against Myocardial Ischemia; M. Hori. 3. The Late Phase of Preconditioning Against Myocardial Stunning; R. Bolli, et al. 4. Coronary Perfusion as the Major Determinant of Myocardial Contractility in the Heart: Implication for Myocardial Hibernation; M. Kitakaze. 5. Myocardial Protection from Reperfusion Injury with Adenosine; J. Vinten-Johansen, Z.-Q. Zhao. III: Cellular Mechanisms of Cardioprotection in Ischemic Preconditioning. 6. Protein Kinase C - the Key-Enzyme in Ischemic Preconditioning? C. Weinbrenner, J.M. Downey. 7. Adenosine, Cardioprotection and Potential Mechanisms; R. Lasley. 8. Activation of Ecto-5'-Nucleotidase Mediates Cardioprotection in Ischemic Preconditioning: Important Role of Protein Kinase C; M. Kitakaze, et al. 9. Role of Mn-SOD Induction in the Second Window Phenomenon of Preconditioning of Ischemic Hearts; T. Kuzuya, et al. 10. Opioid Receptors, KATP Channels and Ischemic Preconditioning; G.J. Gross, J.E. Schultz. 11. Bradykinin and Preconditioning Against Infarction; T. Miura, et al. 12. Preconditioning in Human Muscle and Myocytes; C.S. Carr, D.M. Yellon. 13. Protein Kinase C and Adenosine Synergistically Activate ATP-Sensitive Potassium Currents: Implications for Ischemic Preconditioning; Y. Liu, et al. IV: Clinical Application of New Strategies to Protect the Ischemic Heart. 14. Adenosine and Myocardial Protection in Humans; R.M. Mentzer, Jr. 15. Clinical Applications of Ischemic Preconditioning; Y. Birnbaum, R.A. Kloner. 16. Clinical Pharmacology of Preconditioning and Adenosinergic Drugs; H. van Belle. 17. Clinical Application of Ischemic Preconditioning by ATP-Sensitive Potassium Channel Opener; N. Arakawa, et al. 18. Potassium Channel Openers and Cardiac Surgery; L.P. Perrault, P. Menasché. 19. Anti-ischemic Effects of the ATP-sensitive Potassium Channel Opener During Coronary Angioplasty; S. Saito, et al. 20. Clinical Impact of Ischemic Preconditioning on Infarct Size and Coronary No-Reflow Phenomenon after Successful Recanalization in the Acute Myocardial Infarction; K. Komamura, et al. Index.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

EUR 10,71 per la spedizione da Regno Unito a Italia

Destinazione, tempi e costi

Altre edizioni note dello stesso titolo

9781461346760: Adenosine, Cardioprotection and Its Clinical Application: 194

Edizione in evidenza

ISBN 10:  1461346762 ISBN 13:  9781461346760
Casa editrice: Springer, 2012
Brossura

Risultati della ricerca per Adenosine, Cardioprotection, and Its Clinical Application:...

Foto dell'editore

Editore: Springer, 1997
ISBN 10: 0792399544 ISBN 13: 9780792399544
Nuovo Rilegato

Da: Ria Christie Collections, Uxbridge, Regno Unito

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. In. Codice articolo ria9780792399544_new

Contatta il venditore

Compra nuovo

EUR 170,81
Convertire valuta
Spese di spedizione: EUR 10,71
Da: Regno Unito a: Italia
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Mentzer, Robert M.|Kitakaze, Masafumi|Downey, James M.|Hori, Masatsugu
Editore: Springer US, 1997
ISBN 10: 0792399544 ISBN 13: 9780792399544
Nuovo Rilegato

Da: moluna, Greven, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Gebunden. Condizione: New. I: Adenosine and Cardioprotection. 1. Adenosine and Cardioprotection R.M. Mentzer, Jr., R. Lasley. II: Cardioprotection and Mechanisms of Ischemic And Reperfusion Injury. 2. Concept of Cardioprotection Against Myocardial Ischemia M. Hori. 3. The Late . Codice articolo 458444093

Contatta il venditore

Compra nuovo

EUR 178,14
Convertire valuta
Spese di spedizione: EUR 9,70
Da: Germania a: Italia
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Foto dell'editore

Editore: Springer, 1997
ISBN 10: 0792399544 ISBN 13: 9780792399544
Nuovo Rilegato

Da: Lucky's Textbooks, Dallas, TX, U.S.A.

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Condizione: New. Codice articolo ABLIING23Feb2416190186335

Contatta il venditore

Compra nuovo

EUR 161,74
Convertire valuta
Spese di spedizione: EUR 65,97
Da: U.S.A. a: Italia
Destinazione, tempi e costi

Quantità: Più di 20 disponibili

Aggiungi al carrello

Immagini fornite dal venditore

Robert M Mentzer Jr
Editore: Springer Us Jun 1997, 1997
ISBN 10: 0792399544 ISBN 13: 9780792399544
Nuovo Rilegato

Da: AHA-BUCH GmbH, Einbeck, Germania

Valutazione del venditore 5 su 5 stelle 5 stelle, Maggiori informazioni sulle valutazioni dei venditori

Buch. Condizione: Neu. Neuware - It has been almost 15 years since the fIrst reports appeared indicating that adenosine exerted a .protective effect in ischemic and reperfused myocardium. Numerous experimental studies have shown that adenosine (both exogenous and endogenous adenosine) delays the onset of ischemic contracture, modulates myocardial metabolism during ischemia, attenuates reversible postischemic ventricular dysfunction (myocardial stunning), and reduces myocardial infarct size. Initial studies on adenosine's cardioprotective effect were based on its ability to stimulate postischemic ATP resynthesis, increase coronary blood flow, and reduce heart rate. Although these actions of adenosine are undoubtedly benefIcial to the ischemic/reperfused heart, it now appears that adenosine's cardioprotective effect may be exclusive of these properties. The immense growth in the number of articles on adenosine cardioprotection in the last several years has been related in large part to the hypothesis that adenosine plays a role in ischemic preconditioning. Ischemic preconditioning is the phenomenon in which a brief period of ischemia (and reperfusion) prior to a more prolonged occlusion reduces myocardial infarct size. This form of myocardial protection has received much interest because ischemic preconditioning has been shown to be the most potent means of reducing infarct size in all animal models thus far tested. In fact prior to studies implicating adenosine's role in ischemic preconditioning, adenosine's infarct reducing effect was not well recognized. Codice articolo 9780792399544

Contatta il venditore

Compra nuovo

EUR 247,94
Convertire valuta
Spese di spedizione: EUR 14,99
Da: Germania a: Italia
Destinazione, tempi e costi

Quantità: 2 disponibili

Aggiungi al carrello